New Metals Lab Opens
News Jun 20, 2013
The new laboratory is bigger and better equipped, meaning that RSSL will be able to provide a more thorough, and more efficient investigative service for the food and drinks industries.
Metals such as arsenic, cadmium, lead and mercury are natural occurring chemical compounds. They can be present at various levels in the environment, and can occur as residues in food because of their presence in the environment, as a result of human activities such as farming, industry or car exhausts or from contamination during food processing and storage.
The basic principles of EU legislation on contaminants in food are contained in Regulation 315/93/EEC, and Regulation EC 1881/2006 lays down maximum levels for certain contaminants in foodstuff, including lead, cadmium, mercury and inorganic tin.
RSSL is now superbly equipped to deal with all the analytical challenges posed by different metals in different matrices.
New equipment has been added to enhance RSSL's current capabilities. This includes ICP-MS (inductively coupled plasma mass-spectrometry), ICP-OES (inductively coupled plasma optical emission spectroscopy), AAS (atomic absorption spectrometry), and MP-AES (microwave plasma-atomic emission spectrometry).
These four complementary technologies give RSSL options to quantify trace metal contamination in all kinds of matrices, with accuracy and efficiency not possible by wet-chemistry methods.
As Agilent's sole partner laboratory in the UK for atomic spectroscopy, RSSL will also be established as the premiere site for developing new techniques and applications for Agilent's technologies, benefiting from Agilent's support and expertise, and offering a demonstration site for Agilent equipment.
Advantage of Breastfeeding to Increase Mother-Child BondNews
Researchers have found that the molecule RAGE, on the intestinal epithelium, transports oxytocin into the blood even after neonate gut closure. This finding suggests breastfeeding and oral oxytocin administration is advantageous to increase its concentration in blood and mother-child bond.READ MORE
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to TreatmentNews
Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.READ MORE
BC Platforms Announces Collaborations in Multiple Sclerosis ResearchNews
Company's technology and research platforms used to better understand genetic basis of MS.READ MORE